Saladax Biomedical has signed an agreement to license diagnostic tests for Alzheimer’s disease to Siemens Healthineers. These tests can lead to early identification of Alzheimer’s Disease, which is the sixth leading cause of death in the U.S., affecting nearly 50 million patients worldwide, with 10 million new cases each year. Read more: http://bit.ly/2jnxS9b; Via Morning Call.
Client & Alumni News
Saladax Licenses Alzheimer’s Diagnostics Tests
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.